Tanqi Lou
department
Nephrology
Introduction

Tanqi Lou M.D., Ph.D.


Titles

Professor

Director of Department of Medicine and Division of nephrology,?the Third Affiliated Hospital of Sun Yat-sen University

?

Research Interests ??????????????????????

Glomerular Diseases

Pathogenesis of Diabetic Nephropathy

Chronic Kidney Disease

Hypertension in CKD

?

Education and Experience

Education

M.S. (Master of Medicine) / Ph.D. (Doctor of Medicine) (successive postgraduate and doctoral program) (1987) Sun Yat-sen University, Medical College, Guangzhou, P.R. China

M.D. (1977) Sun Yat-sen University, Medical College, Guangzhou, P.R. China

?

Experience

Professor (2001- ). Division of Nephrology, Department of Medicine, the Third Affiliated Hospital of Sun

Yat-sen University, Guangzhou, P.R. China ???

Associate Professor (1995-2001). Division of Nephrology, Department of Medicine, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, P.R. China

Attending Physician (1992-1994).?Division of Nephrology, Department of Medicine, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, P.R. China


?

Honors and Awards

Dr. Lou is a member of the Sstanding Committee of Chinese Medical Doctor Association Nephrologists Branch and the Vice Chair of Guangdong Province Medical Doctor Association Nephrologists Branch. He is a member of Chinese Medical Association Kidney Disease Branch. Dr Lou is an editor of Chinese Journal of Nephrology, Chinese Journal of Nephrology Dialysis & Transplantation, Journal of the American Society of NephrologyChinese version, Nephrol Dial Transplant, NDT Chinese version, Chinese Journal of Blood Purification and International Journal of Internal Medicine. He has participated as principal investigator in several studies and serves as a peer reviewer for the Natural Science Foundation of China and National Technology Prize.

?

Publications

1.Peng H, Li Y, Wang C, Zhang J, Chen Y, Chen W, Cao J, Wang Y, Hu, Z, Lou, T. ROCK1 Induces Endothelial-to-Mesenchymal Transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy. Sci Rep. 2016; 6: 20304.

2.Wang C, Zhang J, Deng W, Gong W, Liu X, Ye Z, Peng H, Lou?T. Nighttime Systolic Blood-Pressure Load Is Correlated with Target-Organ Damage Independent of Ambulatory Blood-Pressure Level in Patients with Non-Diabetic Chronic Kidney Disease. PLoS One?2015;10(7):e0131546. doi: 10.1371

3.Wang C, Deng W, Gong WY, Zhang J, Tang H, Peng H, Zhang QZ, Ye ZC, Lou?T. High prevalence of isolated nocturnal hypertension in Chinese patients with chronic kidney disease. J Am Heart Assoc?2015 ;4(6):e002025. doi: 10.1161

4.Wang C, Deng W, Gong WY, Zhang J, Zhang QZ, Ye ZC, Lou?T. Nocturnal Hypertension Correlates Better With Target Organ Damage in Patients With Chronic Kidney Disease than a Nondipping Pattern. J Clin Hypertens (Greenwich)?2015. doi: 10.1111/jch.12589

5.Wang C, Gong WY, Zhang J, Peng H, Tang H, Liu X, Ye ZC, Lou?T. Disparate assessment of clinic blood pressure and ambulatory blood pressure in differently aged patients with chronic kidney disease. Int J Cardiol??2015, 183:54-62

6.Wang C?,?Li CC, Peng H, Ye Z, Zhang J, Lou tq. Activation of the Nrf2–ARE pathway attenuates hyperglycemia-mediated injuries in podocytes.?Cell Physiol Biochem?2014,34:891-902

7.Zhang J, Wang C, Tang Y, Peng H, Ye ZC, Li CC, Lou TQ: Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy, Nephrology (Carlton) 2013, 18:125-131

8.Wang C, Zhang J, Liu X, Li CC, Ye ZC, Peng H, Chen Z, Lou T: Effect of valsartan with bedtime dosing on chronic kidney disease patients with nondipping blood pressure pattern, J Clin Hypertens (Greenwich)?2013, 15:48-54

9.Wang C, Zhang J, Liu X, Li C, Ye Z, Peng H, Chen Z, Lou T: Reversed dipper blood-pressure pattern is closely related to severe renal and cardiovascular damage in patients with chronic kidney disease, PloS one 2013, 8:e55419

10.Liu X, Pei X, Li N, Zhang Y, Zhang X, Chen J, Lv L, Ma H, Wu X, Zhao W, Lou T: Improved glomerular filtration rate estimation by an artificial neural network,?PloS one?2013, 8:e58242

11.Wang C, Liu X, Ke Z, Tang Y, Li CC, Li CM, Ye Z, Zhang J, Lou T: Mesangial medium from IgA nephropathy patients induces podocyte epithelial-to-mesenchymal transition through activation of the phosphatidyl inositol-3-kinase/Akt signaling pathway, Cellular physiology and biochemistry?2012, 29:743-752

12.Peng H, Chen WF, Wu C, Chen YR, Peng B, Paudel SD, Lou TQ: Culture-negative subacute bacterial endocarditis masquerades as granulomatosis with polyangiitis (Wegener's granulomatosis) involving both the kidney and lung, BMC nephrology?2012, 13:174

13.Liu X, Lv L, Wang C, Shi C, Cheng C, Tang H, Chen Z, Ye Z, Lou T: Comparison of prediction equations to estimate glomerular filtration rate in Chinese patients with chronic kidney disease, Internal medicine journal?2012, 42:e59-67

14.Liu X, Cheng MH, Shi CG, Wang C, Cheng CL, Chen JX, Tang H, Chen ZJ, Ye ZC, Lou TQ: Variability of glomerular filtration rate estimation equations in elderly Chinese patients with chronic kidney disease, Clinical interventions in aging?2012, 7:409-415

15.Cheng CL, Tang Y, Zheng Z, Liu X, Ye ZC, Wang C, Lou TQ: Advanced glycation end-products activate the renin-angiotensin system through the RAGE/PI3-K signaling pathway in podocytes, Clinical and investigative medicine?2012, 35:E282

16.Wang C, Liu X, Tang Y, Peng H, Ye Z, Zhang J, Tang H, Lou T: Medium from mesangial cells incubated with aggregated IgA1 from IgA nephropathy patients reduces podocyte adhesion through activation of the renin angiotensin system, Swiss medical weekly?2011, 141:w13304

17.Xun L, Cheng W, Hua T, Chenggang S, Zhujiang C, Zengchun Y, Tanqi L: Assessing glomerular filtration rate (GFR) in elderly Chinese patients with chronic kidney disease (CKD): a comparison of various predictive equations, Archives of gerontology and geriatrics?2010, 51:13-20

18..Wang C, Liu X, Peng H, Tang Y, Tang H, Chen Z, Lou T, Zhang H: Mesangial cells stimulated by immunoglobin A1 from IgA nephropathy upregulates transforming growth factor-beta1 synthesis in podocytes via renin-angiotensin system activation, Archives of medical research?2010, 41:255-260

19.Peng H, Wang C, Ye ZC, Chen YR, Zhang J, Chen ZJ, Yu XQ, Lou TQ: How increased VEGF induces glomerular hyperpermeability: a potential signaling pathway of Rac1 activation, Acta diabetologica?2010, 47 Suppl 1:57-63

20.Lou T,?Zhang J, Gale DP, Rees AJ, Rhodes B, Feehally J, Li C, Li Y, Li R, Huang W, Hu B, Leung JC, Lam MF, Lai KN, Wang Y, Maxwell PH: Variation in IGHMBP2 is not associated with IgA nephropathy in independent studies of UK Caucasian and Chinese Han patients, Nephrology, dialysis, transplantation 2010, 25:1547-1554

21.Ye ZC, Wang C, Tang Y, Liu X, Peng H, Zhang H, Lou TQ: Serum IgA1 from patients with IgA nephropathy up-regulates integrin-linked kinase synthesis and inhibits adhesive capacity in podocytes through indirect pathways, Clinical and investigative medicine Medecine?2009, 32:E20-27

22.Wang C, Ye Z, Peng H, Tang H, Liu X, Chen Z, Yu X, Lou T: Effect of aggregated immunoglobulin A1 from immunoglobulin A nephropathy patients on nephrin expression in podocytes, Nephrology (Carlton) 2009, 14:213-218

23.Wang C, Liu X, Ye Z, Zhang J, Tang H, Chen Z, Zhang H, Lou T: Mesangial medium with IgA1 from IgA nephropathy inhibits nephrin expression in mouse podocytes, European journal of clinical investigation?2009, 39:561-567

24.Wang C, Peng H, Tang H, Liu X, Chen Z, Lou T,?Yu X: Serum IgA1 from IgA nephropathy patients induces apoptosis in podocytes through direct and indirect pathways, Clinical and investigative medicine?2007, 30:E240-249

25.Lou T,?Wang C, Chen Z, Shi C, Tang H, Liu X, Yin P, Yu X: Randomised controlled trial of leflunomide in the treatment of immunoglobulin A nephropathy, Nephrology (Carlton) 2006, 11:113-116

?

Contact

Division of Nephrology, Department of Medicine,

The Third Affiliated Hospital of Sun Yat-sen University

# 600 Tianhe Street, Guangzhou, Guangdong, China, 510630

E-mail: lou.tq@163.com

Phone: 8620-85252865